Shopping Cart 0
Cart Subtotal
USD 0

AutoGenomics Inc-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti system is designed for processing AutoGenomics' unique proprietary BioFilmChip microarrays that can be multiplexed and configured biomarkers to assess disease signatures. The company also offers molecular diagnostic products for the in-vitro diagnostic market. It provides online support services to its customers. The company markets its products in Australia, Ireland, Russia, Spain, Turkey, Colombia, Mexico, the UAE, the US and others. AutoGenomics is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company AutoGenomics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

AutoGenomics Inc Company Overview 7

AutoGenomics Inc Company Snapshot 7

AutoGenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 7

AutoGenomics Inc-Pipeline Analysis Overview 11

AutoGenomics Inc-Key Facts 11

AutoGenomics Inc-Major Products and Services 12

AutoGenomics Inc Pipeline Products by Development Stage 13

AutoGenomics Inc Pipeline Products Overview 17

BRAF Mutation Assay 17

BRAF Mutation Assay Product Overview 17

DNA Guided Diagnostic Test-Cardiovascular Disease 18

DNA Guided Diagnostic Test-Cardiovascular Disease Product Overview 18

DNA Guided Diagnostic Test-Diabetes 19

DNA Guided Diagnostic Test-Diabetes Product Overview 19

DNA Guided Diagnostic Test-Obesity 20

DNA Guided Diagnostic Test-Obesity Product Overview 20

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay 21

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay Product Overview 21

INFINITI Bacterial Vaginosis QUAD 22

INFINITI Bacterial Vaginosis QUAD Product Overview 22

INFINITI Buccal Sample Collection Kit 23

INFINITI Buccal Sample Collection Kit Product Overview 23

INFINITI Candida Vaginitis QUAD Assay 24

INFINITI Candida Vaginitis QUAD Assay Product Overview 24

INFINITI CFTR-31 Assay 25

INFINITI CFTR-31 Assay Product Overview 25

INFINITI CYP2C19 Assay 26

INFINITI CYP2C19 Assay Product Overview 26

INFINITI CYP450 2C19+ Assay 27

INFINITI CYP450 2C19+ Assay Product Overview 27

INFINITI CYP450 2C9-VKORC1 Assay 28

INFINITI CYP450 2C9-VKORC1 Assay Product Overview 28

INFINITI CYP450 2D6-BC Assay 29

INFINITI CYP450 2D6-BC Assay Product Overview 29

INFINITI Factor II-V And MTHFR Assay 30

INFINITI Factor II-V And MTHFR Assay Product Overview 30

INFINITI FLU A-sH1N1 31

INFINITI FLU A-sH1N1 Product Overview 31

INFINITI FMF Assay 32

INFINITI FMF Assay Product Overview 32

INFINITI High Throughput System (HTS) 33

INFINITI High Throughput System (HTS) Product Overview 33

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test 34

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test Product Overview 34

INFINITI HPV Genotyping Assay 35

INFINITI HPV Genotyping Assay Product Overview 35

INFINITI HPV-HR Quad Assay 36

INFINITI HPV-HR Quad Assay Product Overview 36

INFINITI KRAS Assay 37

INFINITI KRAS Assay Product Overview 37

INFINITI KRAS-BRAF Assay 38

INFINITI KRAS-BRAF Assay Product Overview 38

INFINITI MTHFR Assay 39

INFINITI MTHFR Assay Product Overview 39

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test 40

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test Product Overview 40

INFINITI PLUS Analyzer 41

INFINITI PLUS Analyzer Product Overview 41

INFINITI RVP Plus Assay 42

INFINITI RVP Plus Assay Product Overview 42

INFINITI SMART 43

INFINITI SMART Product Overview 43

INFINITI SMART-Apo E 44

INFINITI SMART-Apo E Product Overview 44

INFINITI SMART-CYP2C19 45

INFINITI SMART-CYP2C19 Product Overview 45

INFINITI SMART-CYP2C9-VKORC1 46

INFINITI SMART-CYP2C9-VKORC1 Product Overview 46

INFINITI SMART-CYP2D6 47

INFINITI SMART-CYP2D6 Product Overview 47

INFINITI SMART-CYP3A4 48

INFINITI SMART-CYP3A4 Product Overview 48

INFINITI SMART-CYP3A5 49

INFINITI SMART-CYP3A5 Product Overview 49

INFINITI SMART-Factor II 50

INFINITI SMART-Factor II Product Overview 50

INFINITI SMART-Factor V 51

INFINITI SMART-Factor V Product Overview 51

INFINITI SMART-Flu 52

INFINITI SMART-Flu Product Overview 52

INFINITI SMART-HCV 53

INFINITI SMART-HCV Product Overview 53

INFINITI SMART-MTHFR 54

INFINITI SMART-MTHFR Product Overview 54

INFINITI System 55

INFINITI System Product Overview 55

INFINITI System Assay For Factor II 56

INFINITI System Assay For Factor II Product Overview 56

INFINITI System Assay For Factor II-V Leiden 57

INFINITI System Assay For Factor II-V Leiden Product Overview 57

INFINITI System Assay For Factor V Leiden 58

INFINITI System Assay For Factor V Leiden Product Overview 58

INFINITI UGT1A1 Assay 59

INFINITI UGT1A1 Assay Product Overview 59

INFINITI UroGen QUAD Assay 60

INFINITI UroGen QUAD Assay Product Overview 60

Plavix Panel Test 61

Plavix Panel Test Product Overview 61

AutoGenomics Inc-Key Competitors 62

AutoGenomics Inc-Key Employees 63

AutoGenomics Inc-Locations And Subsidiaries 64

Head Office 64

Recent Developments 65

AutoGenomics Inc, Recent Developments 65

Sep 20, 2016: AutoGenomics Introduces its CE-Marked INFINITI Buccal Sample Collection Kit 65

Sep 09, 2016: WuXi AppTec Lab Testing Division and AutoGenomics Form Strategic Partnership to Introduce Advanced Molecular Diagnostic Technology to China 65

Jul 08, 2015: AutoGenomics granted United States patent for Multi-Patient Array technology 65

Apr 28, 2015: AutoGenomics Launches New INFINITI Plus- Hepatitis C Virus Genotyping Test 66

Apr 28, 2015: AutoGenomics Launches New INFINITI High Throughput System-Hepatitis C Virus Genotyping Test 66

Jul 07, 2014: AutoGenomics and Genomas Announce Strategic Partnership for the Development of DNA-Guided Diagnostic Systems for the Treatment of Cardiovascular Disease, Obesity and Diabetes 66

Feb 05, 2014: INFINITI launches High Throughput System 67

Jun 27, 2012: AutoGenomics And ESBE Scientific Receive Health Canada Clearance For INFINITI PGx Testing Platform, Warfarin Assay And 2C19 Assay 67

Dec 21, 2010: AutoGenomics Launches the INFINITI FMF Panel 68

Oct 27, 2010: AutoGenomics Receives FDA Clearance for its INFINITI CYP2C19 Assay 68

Appendix 69

Methodology 69

About GlobalData 71

Contact Us 71

Disclaimer 71


List Of Figure

List of Figures

AutoGenomics Inc Pipeline Products by Equipment Type 8

AutoGenomics Inc Pipeline Products by Development Stage 13


List Of Table

List of Tables

AutoGenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 7

AutoGenomics Inc Pipeline Products by Equipment Type 8

AutoGenomics Inc Pipeline Products by Indication 9

AutoGenomics Inc, Key Facts 11

AutoGenomics Inc, Major Products and Services 12

AutoGenomics Inc Number of Pipeline Products by Development Stage 13

AutoGenomics Inc Pipeline Products Summary by Development Stage 14

BRAF Mutation Assay-Product Status 17

BRAF Mutation Assay-Product Description 17

DNA Guided Diagnostic Test-Cardiovascular Disease-Product Status 18

DNA Guided Diagnostic Test-Cardiovascular Disease-Product Description 18

DNA Guided Diagnostic Test-Diabetes-Product Status 19

DNA Guided Diagnostic Test-Diabetes-Product Description 19

DNA Guided Diagnostic Test-Obesity-Product Status 20

DNA Guided Diagnostic Test-Obesity-Product Description 20

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay-Product Status 21

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay-Product Description 21

INFINITI Bacterial Vaginosis QUAD-Product Status 22

INFINITI Bacterial Vaginosis QUAD-Product Description 22

INFINITI Buccal Sample Collection Kit-Product Status 23

INFINITI Buccal Sample Collection Kit-Product Description 23

INFINITI Candida Vaginitis QUAD Assay-Product Status 24

INFINITI Candida Vaginitis QUAD Assay-Product Description 24

INFINITI CFTR-31 Assay-Product Status 25

INFINITI CFTR-31 Assay-Product Description 25

INFINITI CYP2C19 Assay-Product Status 26

INFINITI CYP2C19 Assay-Product Description 26

INFINITI CYP450 2C19+ Assay-Product Status 27

INFINITI CYP450 2C19+ Assay-Product Description 27

INFINITI CYP450 2C9-VKORC1 Assay-Product Status 28

INFINITI CYP450 2C9-VKORC1 Assay-Product Description 28

INFINITI CYP450 2D6-BC Assay-Product Status 29

INFINITI CYP450 2D6-BC Assay-Product Description 29

INFINITI Factor II-V And MTHFR Assay-Product Status 30

INFINITI Factor II-V And MTHFR Assay-Product Description 30

INFINITI FLU A-sH1N1-Product Status 31

INFINITI FLU A-sH1N1-Product Description 31

INFINITI FMF Assay-Product Status 32

INFINITI FMF Assay-Product Description 32

INFINITI High Throughput System (HTS)-Product Status 33

INFINITI High Throughput System (HTS)-Product Description 33

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test-Product Status 34

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test-Product Description 34

INFINITI HPV Genotyping Assay-Product Status 35

INFINITI HPV Genotyping Assay-Product Description 35

INFINITI HPV-HR Quad Assay-Product Status 36

INFINITI HPV-HR Quad Assay-Product Description 36

INFINITI KRAS Assay-Product Status 37

INFINITI KRAS Assay-Product Description 37

INFINITI KRAS-BRAF Assay-Product Status 38

INFINITI KRAS-BRAF Assay-Product Description 38

INFINITI MTHFR Assay-Product Status 39

INFINITI MTHFR Assay-Product Description 39

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test-Product Status 40

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test-Product Description 40

INFINITI PLUS Analyzer-Product Status 41

INFINITI PLUS Analyzer-Product Description 41

INFINITI RVP Plus Assay-Product Status 42

INFINITI RVP Plus Assay-Product Description 42

INFINITI SMART-Product Status 43

INFINITI SMART-Product Description 43

INFINITI SMART-Apo E-Product Status 44

INFINITI SMART-Apo E-Product Description 44

INFINITI SMART-CYP2C19-Product Status 45

INFINITI SMART-CYP2C19-Product Description 45

INFINITI SMART-CYP2C9-VKORC1-Product Status 46

INFINITI SMART-CYP2C9-VKORC1-Product Description 46

INFINITI SMART-CYP2D6-Product Status 47

INFINITI SMART-CYP2D6-Product Description 47

INFINITI SMART-CYP3A4-Product Status 48

INFINITI SMART-CYP3A4-Product Description 48

INFINITI SMART-CYP3A5-Product Status 49

INFINITI SMART-CYP3A5-Product Description 49

INFINITI SMART-Factor II-Product Status 50

INFINITI SMART-Factor II-Product Description 50

INFINITI SMART-Factor V-Product Status 51

INFINITI SMART-Factor V-Product Description 51

INFINITI SMART-Flu-Product Status 52

INFINITI SMART-Flu-Product Description 52

INFINITI SMART-HCV-Product Status 53

INFINITI SMART-HCV-Product Description 53

INFINITI SMART-MTHFR-Product Status 54

INFINITI SMART-MTHFR-Product Description 54

INFINITI System-Product Status 55

INFINITI System-Product Description 55

INFINITI System Assay For Factor II-Product Status 56

INFINITI System Assay For Factor II-Product Description 56

INFINITI System Assay For Factor II-V Leiden-Product Status 57

INFINITI System Assay For Factor II-V Leiden-Product Description 57

INFINITI System Assay For Factor V Leiden-Product Status 58

INFINITI System Assay For Factor V Leiden-Product Description 58

INFINITI UGT1A1 Assay-Product Status 59

INFINITI UGT1A1 Assay-Product Description 59

INFINITI UroGen QUAD Assay-Product Status 60

INFINITI UroGen QUAD Assay-Product Description 60

Plavix Panel Test-Product Status 61

Plavix Panel Test-Product Description 61

AutoGenomics Inc, Key Employees 63

Glossary 70

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

AutoGenomics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Company Profile

Company Profile Title

Summary

AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti system is designed for processing AutoGenomics' unique proprietary BioFilmChip microarrays that can be multiplexed and configured biomarkers to assess disease signatures. The company also offers molecular diagnostic products for the in-vitro diagnostic market. It provides online support services to its customers. The company markets its products in Australia, Ireland, Russia, Spain, Turkey, Colombia, Mexico, the UAE, the US and others. AutoGenomics is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company AutoGenomics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

AutoGenomics Inc Company Overview 7

AutoGenomics Inc Company Snapshot 7

AutoGenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 7

AutoGenomics Inc-Pipeline Analysis Overview 11

AutoGenomics Inc-Key Facts 11

AutoGenomics Inc-Major Products and Services 12

AutoGenomics Inc Pipeline Products by Development Stage 13

AutoGenomics Inc Pipeline Products Overview 17

BRAF Mutation Assay 17

BRAF Mutation Assay Product Overview 17

DNA Guided Diagnostic Test-Cardiovascular Disease 18

DNA Guided Diagnostic Test-Cardiovascular Disease Product Overview 18

DNA Guided Diagnostic Test-Diabetes 19

DNA Guided Diagnostic Test-Diabetes Product Overview 19

DNA Guided Diagnostic Test-Obesity 20

DNA Guided Diagnostic Test-Obesity Product Overview 20

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay 21

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay Product Overview 21

INFINITI Bacterial Vaginosis QUAD 22

INFINITI Bacterial Vaginosis QUAD Product Overview 22

INFINITI Buccal Sample Collection Kit 23

INFINITI Buccal Sample Collection Kit Product Overview 23

INFINITI Candida Vaginitis QUAD Assay 24

INFINITI Candida Vaginitis QUAD Assay Product Overview 24

INFINITI CFTR-31 Assay 25

INFINITI CFTR-31 Assay Product Overview 25

INFINITI CYP2C19 Assay 26

INFINITI CYP2C19 Assay Product Overview 26

INFINITI CYP450 2C19+ Assay 27

INFINITI CYP450 2C19+ Assay Product Overview 27

INFINITI CYP450 2C9-VKORC1 Assay 28

INFINITI CYP450 2C9-VKORC1 Assay Product Overview 28

INFINITI CYP450 2D6-BC Assay 29

INFINITI CYP450 2D6-BC Assay Product Overview 29

INFINITI Factor II-V And MTHFR Assay 30

INFINITI Factor II-V And MTHFR Assay Product Overview 30

INFINITI FLU A-sH1N1 31

INFINITI FLU A-sH1N1 Product Overview 31

INFINITI FMF Assay 32

INFINITI FMF Assay Product Overview 32

INFINITI High Throughput System (HTS) 33

INFINITI High Throughput System (HTS) Product Overview 33

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test 34

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test Product Overview 34

INFINITI HPV Genotyping Assay 35

INFINITI HPV Genotyping Assay Product Overview 35

INFINITI HPV-HR Quad Assay 36

INFINITI HPV-HR Quad Assay Product Overview 36

INFINITI KRAS Assay 37

INFINITI KRAS Assay Product Overview 37

INFINITI KRAS-BRAF Assay 38

INFINITI KRAS-BRAF Assay Product Overview 38

INFINITI MTHFR Assay 39

INFINITI MTHFR Assay Product Overview 39

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test 40

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test Product Overview 40

INFINITI PLUS Analyzer 41

INFINITI PLUS Analyzer Product Overview 41

INFINITI RVP Plus Assay 42

INFINITI RVP Plus Assay Product Overview 42

INFINITI SMART 43

INFINITI SMART Product Overview 43

INFINITI SMART-Apo E 44

INFINITI SMART-Apo E Product Overview 44

INFINITI SMART-CYP2C19 45

INFINITI SMART-CYP2C19 Product Overview 45

INFINITI SMART-CYP2C9-VKORC1 46

INFINITI SMART-CYP2C9-VKORC1 Product Overview 46

INFINITI SMART-CYP2D6 47

INFINITI SMART-CYP2D6 Product Overview 47

INFINITI SMART-CYP3A4 48

INFINITI SMART-CYP3A4 Product Overview 48

INFINITI SMART-CYP3A5 49

INFINITI SMART-CYP3A5 Product Overview 49

INFINITI SMART-Factor II 50

INFINITI SMART-Factor II Product Overview 50

INFINITI SMART-Factor V 51

INFINITI SMART-Factor V Product Overview 51

INFINITI SMART-Flu 52

INFINITI SMART-Flu Product Overview 52

INFINITI SMART-HCV 53

INFINITI SMART-HCV Product Overview 53

INFINITI SMART-MTHFR 54

INFINITI SMART-MTHFR Product Overview 54

INFINITI System 55

INFINITI System Product Overview 55

INFINITI System Assay For Factor II 56

INFINITI System Assay For Factor II Product Overview 56

INFINITI System Assay For Factor II-V Leiden 57

INFINITI System Assay For Factor II-V Leiden Product Overview 57

INFINITI System Assay For Factor V Leiden 58

INFINITI System Assay For Factor V Leiden Product Overview 58

INFINITI UGT1A1 Assay 59

INFINITI UGT1A1 Assay Product Overview 59

INFINITI UroGen QUAD Assay 60

INFINITI UroGen QUAD Assay Product Overview 60

Plavix Panel Test 61

Plavix Panel Test Product Overview 61

AutoGenomics Inc-Key Competitors 62

AutoGenomics Inc-Key Employees 63

AutoGenomics Inc-Locations And Subsidiaries 64

Head Office 64

Recent Developments 65

AutoGenomics Inc, Recent Developments 65

Sep 20, 2016: AutoGenomics Introduces its CE-Marked INFINITI Buccal Sample Collection Kit 65

Sep 09, 2016: WuXi AppTec Lab Testing Division and AutoGenomics Form Strategic Partnership to Introduce Advanced Molecular Diagnostic Technology to China 65

Jul 08, 2015: AutoGenomics granted United States patent for Multi-Patient Array technology 65

Apr 28, 2015: AutoGenomics Launches New INFINITI Plus- Hepatitis C Virus Genotyping Test 66

Apr 28, 2015: AutoGenomics Launches New INFINITI High Throughput System-Hepatitis C Virus Genotyping Test 66

Jul 07, 2014: AutoGenomics and Genomas Announce Strategic Partnership for the Development of DNA-Guided Diagnostic Systems for the Treatment of Cardiovascular Disease, Obesity and Diabetes 66

Feb 05, 2014: INFINITI launches High Throughput System 67

Jun 27, 2012: AutoGenomics And ESBE Scientific Receive Health Canada Clearance For INFINITI PGx Testing Platform, Warfarin Assay And 2C19 Assay 67

Dec 21, 2010: AutoGenomics Launches the INFINITI FMF Panel 68

Oct 27, 2010: AutoGenomics Receives FDA Clearance for its INFINITI CYP2C19 Assay 68

Appendix 69

Methodology 69

About GlobalData 71

Contact Us 71

Disclaimer 71


List Of Figure

List of Figures

AutoGenomics Inc Pipeline Products by Equipment Type 8

AutoGenomics Inc Pipeline Products by Development Stage 13


List Of Table

List of Tables

AutoGenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 7

AutoGenomics Inc Pipeline Products by Equipment Type 8

AutoGenomics Inc Pipeline Products by Indication 9

AutoGenomics Inc, Key Facts 11

AutoGenomics Inc, Major Products and Services 12

AutoGenomics Inc Number of Pipeline Products by Development Stage 13

AutoGenomics Inc Pipeline Products Summary by Development Stage 14

BRAF Mutation Assay-Product Status 17

BRAF Mutation Assay-Product Description 17

DNA Guided Diagnostic Test-Cardiovascular Disease-Product Status 18

DNA Guided Diagnostic Test-Cardiovascular Disease-Product Description 18

DNA Guided Diagnostic Test-Diabetes-Product Status 19

DNA Guided Diagnostic Test-Diabetes-Product Description 19

DNA Guided Diagnostic Test-Obesity-Product Status 20

DNA Guided Diagnostic Test-Obesity-Product Description 20

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay-Product Status 21

INFINITI 2C9 & VKORC 1 Multiplex Warfarin Assay-Product Description 21

INFINITI Bacterial Vaginosis QUAD-Product Status 22

INFINITI Bacterial Vaginosis QUAD-Product Description 22

INFINITI Buccal Sample Collection Kit-Product Status 23

INFINITI Buccal Sample Collection Kit-Product Description 23

INFINITI Candida Vaginitis QUAD Assay-Product Status 24

INFINITI Candida Vaginitis QUAD Assay-Product Description 24

INFINITI CFTR-31 Assay-Product Status 25

INFINITI CFTR-31 Assay-Product Description 25

INFINITI CYP2C19 Assay-Product Status 26

INFINITI CYP2C19 Assay-Product Description 26

INFINITI CYP450 2C19+ Assay-Product Status 27

INFINITI CYP450 2C19+ Assay-Product Description 27

INFINITI CYP450 2C9-VKORC1 Assay-Product Status 28

INFINITI CYP450 2C9-VKORC1 Assay-Product Description 28

INFINITI CYP450 2D6-BC Assay-Product Status 29

INFINITI CYP450 2D6-BC Assay-Product Description 29

INFINITI Factor II-V And MTHFR Assay-Product Status 30

INFINITI Factor II-V And MTHFR Assay-Product Description 30

INFINITI FLU A-sH1N1-Product Status 31

INFINITI FLU A-sH1N1-Product Description 31

INFINITI FMF Assay-Product Status 32

INFINITI FMF Assay-Product Description 32

INFINITI High Throughput System (HTS)-Product Status 33

INFINITI High Throughput System (HTS)-Product Description 33

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test-Product Status 34

INFINITI High Throughput System-Hepatitis C Virus (HCV) Genotyping Test-Product Description 34

INFINITI HPV Genotyping Assay-Product Status 35

INFINITI HPV Genotyping Assay-Product Description 35

INFINITI HPV-HR Quad Assay-Product Status 36

INFINITI HPV-HR Quad Assay-Product Description 36

INFINITI KRAS Assay-Product Status 37

INFINITI KRAS Assay-Product Description 37

INFINITI KRAS-BRAF Assay-Product Status 38

INFINITI KRAS-BRAF Assay-Product Description 38

INFINITI MTHFR Assay-Product Status 39

INFINITI MTHFR Assay-Product Description 39

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test-Product Status 40

INFINITI Plus-Hepatitis C Virus (HCV) Genotyping Test-Product Description 40

INFINITI PLUS Analyzer-Product Status 41

INFINITI PLUS Analyzer-Product Description 41

INFINITI RVP Plus Assay-Product Status 42

INFINITI RVP Plus Assay-Product Description 42

INFINITI SMART-Product Status 43

INFINITI SMART-Product Description 43

INFINITI SMART-Apo E-Product Status 44

INFINITI SMART-Apo E-Product Description 44

INFINITI SMART-CYP2C19-Product Status 45

INFINITI SMART-CYP2C19-Product Description 45

INFINITI SMART-CYP2C9-VKORC1-Product Status 46

INFINITI SMART-CYP2C9-VKORC1-Product Description 46

INFINITI SMART-CYP2D6-Product Status 47

INFINITI SMART-CYP2D6-Product Description 47

INFINITI SMART-CYP3A4-Product Status 48

INFINITI SMART-CYP3A4-Product Description 48

INFINITI SMART-CYP3A5-Product Status 49

INFINITI SMART-CYP3A5-Product Description 49

INFINITI SMART-Factor II-Product Status 50

INFINITI SMART-Factor II-Product Description 50

INFINITI SMART-Factor V-Product Status 51

INFINITI SMART-Factor V-Product Description 51

INFINITI SMART-Flu-Product Status 52

INFINITI SMART-Flu-Product Description 52

INFINITI SMART-HCV-Product Status 53

INFINITI SMART-HCV-Product Description 53

INFINITI SMART-MTHFR-Product Status 54

INFINITI SMART-MTHFR-Product Description 54

INFINITI System-Product Status 55

INFINITI System-Product Description 55

INFINITI System Assay For Factor II-Product Status 56

INFINITI System Assay For Factor II-Product Description 56

INFINITI System Assay For Factor II-V Leiden-Product Status 57

INFINITI System Assay For Factor II-V Leiden-Product Description 57

INFINITI System Assay For Factor V Leiden-Product Status 58

INFINITI System Assay For Factor V Leiden-Product Description 58

INFINITI UGT1A1 Assay-Product Status 59

INFINITI UGT1A1 Assay-Product Description 59

INFINITI UroGen QUAD Assay-Product Status 60

INFINITI UroGen QUAD Assay-Product Description 60

Plavix Panel Test-Product Status 61

Plavix Panel Test-Product Description 61

AutoGenomics Inc, Key Employees 63

Glossary 70

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

AutoGenomics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies